Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chernov, S. Strerlikov, E. Bogorodskaya (Moscow, Russian Federation). Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes. Eur Respir J 2012; 40: Suppl. 56, 2658

Member's Comments

No comment yet.

Related content which might interest you: Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008 Effect on treatment of giving information about tuberculosis to the tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 644s Year: 2005 The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001 Influence of thyroid state on clinical running of tuberculosis and chemotherapy outcomes in concomitant diabetes Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Impact of social of social risk factor on treatment outcome in patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Analysis of the pulmonary tuberculosis patients social status Source: Eur Respir J 2004; 24: Suppl. 48, 191s Year: 2004 A choice of regimen improves completion for patients with latent TB infection Source: Breathe 2008; 4: 366 Year: 2008 Social determinants of non-successful treatment outcome in culture confirmed pulmonary TB patients in Poland Source: Annual Congress 2007 - Tuberculosis control Year: 2007 Efficacy of linezolide-free chemotherapy schemes in patients with highly drug-resistant tuberculosis Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Success of re-treatment regime and influencing factors in patients with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 On the efficiency of the long-term hospitalization treatment of patients with social problems with severe pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002 Predicting outcomes and drug resistance with standardised treatment of active tuberculosis Source: Eur Respir J 2010; 36: 870-877 Year: 2010 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Outcomes of treatment of latent tuberculosis infection in children with two different regimens Source: Eur Respir J 2006; 28: Suppl. 50, 487s Year: 2006 Impact of mono- and poli-resistance on the treatment outcomes of pulmonary tuberculosis Source: International Congress 2017 – MDRTB: detection and management Year: 2017 The reasons of unfavorable outcomes of treatment in pulmonary tuberculosis patients in Kyrgyzstan Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004 Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007